CervoMed Q1 EPS $(0.56) Beats $(0.66) Estimate, Sales $1.92M Beat $1.72M Estimate
CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.66) by 15.15 percent. This is a 36.59 percent decrease over losses of $(0.41) per share from the same
